Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.

Schäfer TE, Knol LI, Haas FV, Hartley A, Pernickel SCS, Jády A, Finkbeiner MSC, Achberger J, Arelaki S, Modic Ž, Schröer K, Zhang W, Schmidt B, Schuster P, Haferkamp S, Doerner J, Gebauer F, Ackermann M, Kvasnicka HM, Kulkarni A, Bots STF, Kemp V, Hawinkels LJAC, Poetsch AR, Hoeben RC, Ehrhardt A, Marchini A, Ungerechts G, Ball CR, Engeland CE.

Open source

DOI: 10.1016/j.ebiom.2024.105219
Published: 2024-06-27
Container: EBioMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2024.105219,
  title = {Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.},
  author = {Schäfer TE and  Knol LI and  Haas FV and  Hartley A and  Pernickel SCS and  Jády A and  Finkbeiner MSC and  Achberger J and  Arelaki S and  Modic Ž and  Schröer K and  Zhang W and  Schmidt B and  Schuster P and  Haferkamp S and  Doerner J and  Gebauer F and  Ackermann M and  Kvasnicka HM and  Kulkarni A and  Bots STF and  Kemp V and  Hawinkels LJAC and  Poetsch AR and  Hoeben RC and  Ehrhardt A and  Marchini A and  Ungerechts G and  Ball CR and  Engeland CE.},
  year = {2024},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2024.105219},
  url = {https://doi.org/10.1016/j.ebiom.2024.105219}
}

RIS

TY  - JOUR
TI  - Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.
AU  - Schäfer TE
AU  -  Knol LI
AU  -  Haas FV
AU  -  Hartley A
AU  -  Pernickel SCS
AU  -  Jády A
AU  -  Finkbeiner MSC
AU  -  Achberger J
AU  -  Arelaki S
AU  -  Modic Ž
AU  -  Schröer K
AU  -  Zhang W
AU  -  Schmidt B
AU  -  Schuster P
AU  -  Haferkamp S
AU  -  Doerner J
AU  -  Gebauer F
AU  -  Ackermann M
AU  -  Kvasnicka HM
AU  -  Kulkarni A
AU  -  Bots STF
AU  -  Kemp V
AU  -  Hawinkels LJAC
AU  -  Poetsch AR
AU  -  Hoeben RC
AU  -  Ehrhardt A
AU  -  Marchini A
AU  -  Ungerechts G
AU  -  Ball CR
AU  -  Engeland CE.
PY  - 2024
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2024.105219
UR  - https://doi.org/10.1016/j.ebiom.2024.105219
ER  -

APA

TE, S., LI, K., FV, H., A, H., SCS, P., A, J., MSC, F., J, A., S, A., Ž, M., K, S., W, Z., B, S., P, S., S, H., J, D., F, G., M, A., HM, K., A, K., STF, B., V, K., LJAC, H., AR, P., RC, H., A, E., A, M., G, U., CR, B., & CE., E. (2024). Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105219

Source records

europe-pmc · retrieved 2026-09-25T07:27:18.342Z
doaj · retrieved 2026-09-25T07:27:18.350Z